These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 91433)

  • 21. [Importance of the intracellular detection of alpha-fetoprotein and beta-human chorionic gonadotropin in a testicular tumor using immunoperoxidase].
    Schwarz HP; Susani M; Kratzik C; Studler G; Krisch K; Aiginger P
    Wien Klin Wochenschr; 1984 Mar; 96(6):230-4. PubMed ID: 6204462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. False-positive and false-negative alpha-feto protein and human chorionic gonadotropin assays in testicular cancer: a double blind study.
    Javadpour N; Soares T
    Cancer; 1981 Nov; 48(10):2279-81. PubMed ID: 6170418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular localization of AFP, hCG and its free subunits, and SP1 in embryonal carcinoma of the testis and ovary.
    Furumoto M
    Pathol Res Pract; 1981 Dec; 173(1-2):12-21. PubMed ID: 6174958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localization of alpha-fetoprotein and human chorionic gonadotropin to specific histologic types of nonseminomatous testicular cancer.
    Fowler JE; Sesterhenn I; Stutzman RE; Mostofi FK
    Urology; 1983 Dec; 22(6):649-54. PubMed ID: 6196899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
    Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
    J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tumor markers in germ cell tumors. Clinical use and research aspects].
    Clausen PP; Nørgaard-Pedersen B; Arends J; Ingild A; Jacobsen GK; Jacobsen M; Juhl BR; Kjaersgaard E; Nissen MH; Schultz-Larsen P; Toftager-Larsen K; Zeuthen J
    Ugeskr Laeger; 1982 May; 144(18):1285-90. PubMed ID: 6181594
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical studies of testicular tumor. I. Analysis of 27 patients with seminoma: the clinical significance of hCG-beta determination and of retroperitoneal lymph node dissection for stage I patients].
    Tsukamoto T; Kumamoto Y; Ohmura K; Tsunekawa T; Yamazaki K
    Hinyokika Kiyo; 1986 Jul; 32(7):989-97. PubMed ID: 2430436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologic tumor markers in management of testicular and bladder cancer.
    Javadpour N
    Urology; 1978 Aug; 12(2):177-83. PubMed ID: 80871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The significance of alpha-fetoprotein in the serum of patients with malignant teratomas and related gonadal neoplasms.
    Ballas M
    Ann Clin Lab Sci; 1974; 4(4):267-75. PubMed ID: 4142543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of elevated serum alphafetoprotein (AFP) in seminoma.
    Javadpour N
    Cancer; 1980 Apr; 45(8):2166-8. PubMed ID: 6154525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor markers and pathology of testicular tumors.
    Mostofi FK
    Prog Clin Biol Res; 1984; 153():69-87. PubMed ID: 6206511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lactic dehydrogenase in the monitoring and prognosis of testicular cancer.
    Lippert MC; Javadpour N
    Cancer; 1981 Nov; 48(10):2274-8. PubMed ID: 6170417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Beta-HCG positive seminoma--incidence with special reference to tumor marker concentration in testicular venous blood].
    Mumperow E; Kressel K; Hartmann M
    Urologe A; 1991 Mar; 30(2):114-6; discussion 117. PubMed ID: 1711727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human chorionic gonadotropin-positive seminoma: is this a special type of seminoma with a poor prognosis?
    Scheiber K; Mikuz G; Frommhold H; Bartsch G
    Prog Clin Biol Res; 1985; 203():97-104. PubMed ID: 3832120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of alpha-fetoprotein mRNA in seminoma.
    Yuasa T; Yoshiki T; Ogawa O; Tanaka T; Isono T; Mishina M; Higuchi K; Okada Y; Yoshida O
    J Androl; 1999; 20(3):336-40. PubMed ID: 10386812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of serum AFP, HCG, and CEA in testicular tumor].
    Miki T; Oda H; Kamei O; Saiki S; Kinouchi T; Kuroda M; Yoshida M; Kiyohara H; Usami M; Osafune M
    Nihon Hinyokika Gakkai Zasshi; 1983 Jul; 74(7):1236-47. PubMed ID: 6198548
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
    Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
    Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
    Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
    J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.